Trichosporon beigelli infection a child with congenital extrophy bladder

  • Badhuli Samal, Bisure K, Shastri J

Abstract

no abstract

References

1. Rippon JW. Superficial infections. In: Rippon JW (ed). Medical Mycology. 2nd edn:WB Saunders: Philadelphia, 1979, pp 148-151.
2. Hoy J, Hsu KC, Rolston K et al. Trichosporon beigelii infection: a review. Rev InfectDis. 1986; 8: 959-967.
3. Yoss BS, Sautter RL, Brenker HJ. Trichosporon beigelii, a new neonatal pathogen. Am J Perinatol. 1997; 14: 113-117.
4. Keay S, Denning DW, Stevens DA. Endocarditis due to Trichosporon beigelii: in vitro susceptibility of isolates and review. Rev Infect Dis. 1991; 13: 383-386.
5. Brahn E, Leonard PA. Trichosporon cutaneum endocarditis: a sequela of intravenous drug-abuse. Am J Clin Path. 1982; 78: 792-794.
6. Ashpole RD, Jacobson K, King AT, Holmes AE. Cystoperitoneal shunt infection with Trichosporon beigelii. Br JNeurosurg. 1991; 5: 515-517.
7. Muramatsu H, Kume H, Hojo M et al. A case of Trichosporon beigelii peritonitis in CAPD. Kansenshogaku Zasshi. 1992; 66: 1129-1132.
8. Mathews MS, Prabhakar S. Chronic meningitis caused by Trichosporonbeigelii in India. Mycoses. 1995; 38: 125-126.
9. Bottari M, D’Amore F, Buda CA et al. Stenosing esophagitis caused byTrichosporon beigelii: presentation of a rare case. G Chir. 1997; 18: 344-347.
10. Sheikh HA, Mahgoub S, Badi K. Postoperative endophthalmitis due to Trichosporon cutaneum. Br J Ophthalmol. 1974; 58: 591-594.
11. Gardella S, Nomdedeu B, Bombi JA et al. Fatal fungemia with arthritic involvement caused by Trichosporon beigelii in a bone marrow transplant recipient. J Infect Dis.1985; 151: 566.
12. Patel SA, Borges MC, Batt MD, Rosenblate JH. Trichosporon cholangitis associated with hyperbilirubinemia and findings suggesting primary sclerosing cholangitis on endoscopic
retrograde cholangiopancreatography. Am J Gastroenterol. 1990; 85: 84-87
13. Korinek JK, Guarda LA, Bolivar R, Stroehlein JR. Trichosporon hepatitis. Gastroenterology. 1983; 85: 732-734.
14. Goodman JL, Winston DJ, Greenfield RA et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New Engl JMed. 1992; 326: 845-851.
15. Slavin MA, Osborne B, Adams R et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind
study. JInfect Dis. 1995; 171: 1545-1552.
16. Ellis ME, Clink H, Ernst P et al. Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 1994; 13: 311,MEDLINE
17. O’Donnell MR, Schmidt GM, Tegtmeier BR et al. Prediction of systemic fungal infection in allogeneic marrow recipients. Impact of amphotericin prophylaxis in high-risk patients. J ClinOncol. 1994; 12: 827-834.
18. Jesse L, Goodman MD, Drew J et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New Engl J Med. 1992; 326: 845-851.
19. Perfect JR, Schell WA. The new fungal opportunists are coming. Clin Infect Dis.1996; 22(2): S112-S118.
20. Watson KC, Kallichurum S. Brain abscess due to Trichosporon cutaneum. J Med Microbiol. 1970; 3:191-193.
Published
2019-08-06
How to Cite
Badhuli Samal, Bisure K, Shastri J. (2019). Trichosporon beigelli infection a child with congenital extrophy bladder. The Indian Practitioner, 68(12), 43-44. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/519